The best Bull and Bear pitches based on recency and number of recommendations.
I believe the buyout rumors.
Veltassa sounds like a nice little drug, and I hope Relypsa does well, but it’s not for me. There is simply too much risk and uncertainty, especially from looming competition. Ultimately, I suspect that Relypsa — if it’s not bought out — will have to… More
Read the most recent pitches from players about RLYP.DL.
Find the members with the highest scoring picks in RLYP.DL.
See what the Wall Street professionals think, according to their public statements and filings.